Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis clinical trials

Explore recruiting non alcoholic steatohepatatis nash is the progressive form of non alcoholic fatty liver disease nafld with a prevalence of approximately 2 to 3 of the general population non alcoholic steatohepatitis can lead to cirrhosis and its complications hepatocellular carcinoma and end stage liver disease non alcoholic steatohepatitis is defined histologically as a multicomponent condition composed of hepatic steatosis inflammation and hepatocyte ballooning in varying proportions nash differs from steatosis alone by the presence of hepatic cell inflammation and injury in response to lipotoxic intermediates that are accumulated and metabolized in the steatotic liver nash is closely associated with metabolic risk factors including obesity t2dm and dyslipidemia pathophysiologically nash is frequently associated with a hyperinsulinemic or insulin resistant state leading to adipose tissue dysfunction and increased hepatic de novo lipogenesis clinical trials.

Also recruiting in Europe

Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase IIa, Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety, Tolerability, and Pharmacodynamics of AZD4831 in Participants with Non-cirrhotic Non-alcoholic Steatohepatitis (NASH) with Fibrosis

Sweden, Spain, Denmark, Italy, Norway, Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis trials by city

Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Toronto Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Vancouver Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Montreal Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Calgary Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Edmonton Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Ottawa Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Winnipeg Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Quebec City Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Hamilton Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Kitchener Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in London Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Halifax Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in New York Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Los Angeles Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Chicago Non Alcoholic Steatohepatatis Nash Is The Progressive Form Of Non Alcoholic Fatty Liver Disease Nafld With A Prevalence Of Approximately 2 To 3 Of The General Population Non Alcoholic Steatohepatitis Can Lead To Cirrhosis And Its Complications Hepatocellular Carcinoma And End Stage Liver Disease Non Alcoholic Steatohepatitis Is Defined Histologically As A Multicomponent Condition Composed Of Hepatic Steatosis Inflammation And Hepatocyte Ballooning In Varying Proportions Nash Differs From Steatosis Alone By The Presence Of Hepatic Cell Inflammation And Injury In Response To Lipotoxic Intermediates That Are Accumulated And Metabolized In The Steatotic Liver Nash Is Closely Associated With Metabolic Risk Factors Including Obesity T2dm And Dyslipidemia Pathophysiologically Nash Is Frequently Associated With A Hyperinsulinemic Or Insulin Resistant State Leading To Adipose Tissue Dysfunction And Increased Hepatic De Novo Lipogenesis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease